coronavirus
cov
larg
famili
envelop
singlestrand
zoonot
rna
virus
four
cov
commonli
circul
among
human
howev
cov
rapidli
mutat
recombin
lead
novel
cov
spread
anim
human
novel
cov
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
novel
coronaviru
current
caus
sever
outbreak
diseas
term
china
multipl
countri
threaten
caus
global
pandem
human
cov
mostli
caus
respiratori
gastrointestin
symptom
clinic
manifest
rang
common
cold
sever
diseas
bronchiti
pneumonia
sever
acut
respiratori
distress
syndrom
multiorgan
failur
even
death
sarscov
merscov
seem
less
commonli
affect
children
caus
fewer
symptom
less
sever
diseas
age
group
compar
adult
associ
much
lower
casefat
rate
preliminari
evid
suggest
children
like
adult
becom
infect
less
like
symptomat
develop
sever
symptom
howev
import
children
transmit
viru
remain
uncertain
children
often
gastrointestin
symptom
compar
adult
children
sarscov
present
fever
case
novel
cov
mani
children
affect
merscov
asymptomat
major
children
infect
novel
cov
document
household
contact
often
show
symptom
contrast
adult
often
nosocomi
exposur
review
summar
epidemiolog
clinic
diagnost
find
well
treatment
prevent
option
common
circul
novel
cov
infect
human
focu
infect
children
betacoronaviru
initi
emerg
guangdong
provinc
south
china
spread
hong
kong
rapidli
mani
countri
caus
sever
lower
respiratori
tract
infect
sever
morbid
high
casefat
rate
approach
individu
year
age
overal
persontoperson
transmiss
sarscov
well
establish
viru
spread
countri
estim
caus
infect
death
worldwid
tabl
merscov
novel
group
betacoronaviru
first
appear
saudi
arabia
spread
persontoperson
caus
sever
lower
respiratori
tract
infect
casefat
rate
apart
endem
middl
east
nosocomi
outbreak
merscov
south
korea
involv
hospit
patient
caus
medic
doctor
return
middl
east
merscov
spread
countri
caus
estim
infect
death
tabl
overal
reproduct
number
sarscov
estim
merscov
tabl
larg
depend
geograph
locat
stage
outbreak
inclus
nosocomi
versu
gener
transmiss
virus
associ
earli
superspread
event
sarscov
merscov
larg
number
secondari
infect
mostli
associ
nosocomi
outbreak
sarscov
case
mostli
health
care
worker
merscov
case
mostli
patient
occur
nosocomi
transmiss
superspread
event
follow
reduc
spread
follow
gener
virus
decreas
sarscov
merscov
tabl
therefor
sarscov
merscov
low
potenti
longterm
sustain
commun
transmiss
human
sarscov
infect
detect
sinc
juli
howev
sarscovlik
virus
found
bat
known
abl
infect
human
cell
without
adapt
make
possibl
sarscov
reemerg
happen
zoonot
transmiss
merscov
human
continu
attribut
role
dromedari
camel
reservoir
close
contact
human
contrast
humanbatinteract
sd
sd
shed
durat
children
daycar
mostli
onset
symptom
mostli
onset
symptom
unknown
asymptomat
proport
children
asymptomat
asymptomat
asymptomat
asymptomat
clinic
featur
children
fever
rhiniti
conjunct
otiti
pharyng
laryng
croup
headach
bronchiti
bronchiol
wheez
asthma
exacerb
pneumonia
normal
reduc
wbc
decreas
neutrophil
count
decreas
neutrophil
count
decreas
lymphocyt
count
decreas
lymphocyt
count
thrombocytopenia
thrombocytopenia
crp
pct
level
usual
normal
increas
alanin
aminotransferas
normal
liver
function
test
abnorm
liver
function
test
increas
lactat
dehydrogenas
increas
lactat
dehydrogenas
normal
urea
creatinin
level
derang
coagul
increas
ddimer
sever
case
increas
monoplex
rtpcr
stool
routin
rtpcr
stool
routin
rtpcr
stool
routin
serolog
rtpcr
avail
serolog
acut
phase
serolog
acut
phase
casefat
rate
adult
sporad
case
report
immunosuppress
adult
current
estim
incub
period
estim
day
similar
sarscov
merscov
serial
interv
estim
day
also
similar
novel
cov
tabl
march
world
health
organ
report
spread
countri
caus
infect
death
time
casefat
rate
uncertain
estim
much
lower
sarscov
merscov
respect
children
common
circul
hcov
caus
common
cold
symptom
fever
rhiniti
otiti
pharyng
laryng
headach
also
bronchiti
bronchiol
wheez
pneumonia
case
gastrointestin
symptom
common
children
adult
studi
includ
children
adult
fatigu
headach
myalgia
sore
throat
common
hcovinfect
patient
compar
rsvinfect
patient
fever
cough
dyspnea
frequent
later
fewer
patient
infect
hcov
fever
compar
infect
rsv
influenza
children
associ
conjunct
croup
asthma
exacerb
febril
seizur
febril
seizur
rare
case
neurolog
diseas
also
describ
eg
detect
hcov
cerebrospin
fluid
child
present
acut
dissemin
encephalomyel
cerebrospin
fluid
adult
multipl
sclerosi
suspect
associ
hcov
kawasaki
diseas
could
confirm
common
hcov
isol
asymptomat
individu
infect
viral
load
high
first
day
decreas
thereaft
correl
viral
load
sever
diseas
observ
contrast
sarscov
higher
initi
viral
load
independ
associ
wors
prognosi
includ
higher
casefat
rate
viru
particl
isol
nasopharyng
secret
day
onset
infect
case
seri
report
total
children
affect
sarscov
viru
associ
milder
diseas
children
compar
adult
death
report
children
symptomat
children
sarscov
infect
report
fever
myalgia
rhiniti
sore
throat
cough
dyspnea
headach
less
commonli
vomit
abdomin
pain
diarrhea
febril
seizur
total
children
famili
member
infect
nosocomi
contact
sarscov
children
recov
quickli
infect
sarscov
howev
abnorm
chest
comput
tomographi
ct
persist
sever
month
eg
air
trap
groundglass
opacif
evid
sarscov
vertic
transmit
fetu
howev
sarscov
infect
pregnanc
associ
possibl
miscarriag
intrauterin
growth
retard
preterm
deliveri
case
seri
patient
infect
merscov
report
low
proport
children
tabl
small
case
seri
children
infect
merscov
one
includ
children
mean
age
year
one
children
studi
children
asymptomat
case
seri
children
suffer
fever
vomit
diarrhea
cough
short
breath
two
children
requir
oxygen
supplement
one
mechan
ventil
case
seri
die
main
sourc
merscov
infect
children
household
contact
follow
nosocomi
transmiss
eight
case
merscov
matern
infect
pregnanc
report
occur
week
pregnanc
three
affect
infant
die
differ
case
definit
case
adult
children
authorit
sourc
march
detail
tabl
children
less
commonli
affect
chines
center
diseas
control
prevent
report
case
report
februari
individu
less
year
age
case
seri
children
infect
first
includ
children
januari
provinc
zhejiang
second
children
januari
februari
provinc
shenzhen
third
infant
differ
provinc
china
case
seri
children
provid
clinic
detail
none
children
underli
diseas
common
respiratori
symptom
mild
diseas
asymptomat
common
symptom
fever
cough
case
seri
children
present
low
moder
fever
rhiniti
cough
fatigu
headach
diarrhea
sever
case
dyspnea
cyanosi
poor
feed
number
specifi
seri
infant
report
fever
one
infant
asymptomat
addit
asymptomat
children
infect
outsid
case
seri
also
describ
eg
asymptomat
child
radiolog
groundglass
lung
opac
chest
ct
infect
children
recov
week
onset
symptom
death
report
februari
seri
appear
children
milder
clinic
symptom
adult
report
sarscov
merscov
infect
could
mean
children
might
test
frequent
adult
therefor
suggest
asymptomat
mildli
symptomat
children
might
transmit
diseas
howev
major
children
infect
thu
far
part
famili
cluster
outbreak
infant
seri
famili
member
symptom
infant
case
case
seri
children
major
one
children
exact
number
specifi
similar
sarscov
children
report
affect
household
contact
merscov
studi
prepublish
earli
march
suggest
children
like
adult
becom
infect
less
like
symptomat
develop
sever
symptom
howev
import
children
transmit
viru
remain
uncertain
small
case
seri
mother
infect
date
evid
vertic
transmit
infant
laboratori
find
children
similar
infect
caus
differ
novel
cov
tabl
white
blood
cell
count
typic
normal
reduc
decreas
neutrophil
andor
lymphocyt
count
thrombocytopenia
may
occur
creactiv
protein
procalcitonin
level
often
normal
sever
case
elev
liver
enzym
lactat
dehydrogenas
level
well
abnorm
coagul
elev
ddimer
report
laboratori
find
observ
children
infect
case
seri
children
white
blood
cell
count
normal
neutropenia
lymphopenia
found
case
lactat
dehydrogenas
level
elev
case
creactiv
protein
procalcitonin
level
elev
case
similar
laboratori
find
radiolog
find
children
also
similar
across
infect
differ
novel
cov
tabl
chest
radiographi
children
mostli
show
bilater
patchi
airspac
consolid
often
peripheri
lung
peribronchi
thicken
groundglass
opac
chest
ct
mostli
show
airspac
consolid
groundglass
opac
ct
chang
observ
children
infect
includ
bilater
multipl
patchi
nodular
groundglass
opac
fever
signssymptom
lower
respiratori
ill
eg
cough
short
breath
close
contact
laboratoryconfirm
patient
within
symptom
onset
b
fever
signssymptom
lower
respiratori
ill
eg
cough
short
breath
histori
travel
hubei
provinc
china
within
symptom
onset
c
fever
signssymptom
lower
respiratori
ill
eg
cough
short
breath
requir
hospit
histori
mainland
china
within
symptom
onset
suspect
case
patient
acut
respiratori
infect
fever
least
one
signsymptom
respiratori
diseas
eg
cough
short
breath
etiolog
fulli
explain
clinic
present
histori
travel
resid
countryarea
territori
report
local
transmiss
day
prior
symptom
onset
b
patient
acut
respiratori
ill
contact
confirm
probabl
case
last
day
prior
onset
symptom
c
patient
sever
acut
respiratori
infect
requir
hospit
etiolog
fulli
explain
clinic
present
suspect
probabl
case
defin
case
meet
two
clinic
criteria
one
epidemiolog
criterion
clinic
criteria
fever
fatigu
dri
cough
pediatr
patient
may
fever
patient
follow
chest
imag
find
multipl
small
patchi
shadow
interstiti
chang
mostli
lung
peripheri
bilater
multipl
groundgal
opac
infiltr
shadow
pulmonari
consolid
chest
radiographi
groundglass
opac
bilater
segment
lung
consolid
especi
peripheri
chest
ct
white
blood
cell
count
normal
decreas
decreas
lymphocyt
count
epidemiolog
criteria
children
travel
resid
histori
wuhan
citi
neighbor
area
area
persist
local
transmiss
within
prior
diseas
onset
children
histori
contact
patient
fever
respiratori
symptom
travel
resid
histori
wuhan
citi
neighbor
area
area
persist
local
transmiss
within
prior
diseas
onset
children
histori
contact
confirm
suspect
case
infect
within
prior
diseas
onset
children
relat
cluster
outbreak
addit
patient
patient
fever
respiratori
symptom
includ
suspect
confirm
case
infect
newborn
deliv
suspect
confirm
mother
confirm
case
defin
case
meet
follow
criteria
speckl
groundglass
opac
andor
infiltr
shadow
middl
outer
zone
lung
pleura
find
unspecif
milder
compar
adult
main
basi
diagnosi
infect
hcov
realtim
polymeras
chain
reaction
rtpcr
upper
lower
respiratori
secret
sarscov
merscov
higher
viral
load
detect
sampl
lower
respiratori
tract
compar
upper
respiratori
tract
therefor
clinic
suspect
case
initi
neg
result
nasopharyng
throat
swab
repeat
test
upper
respiratori
tract
sampl
prefer
test
lower
respiratori
tract
sampl
done
rtpcr
stool
sampl
posit
hcov
use
routin
diagnosi
sarscov
rare
case
posit
pcr
blood
report
serolog
use
diagnos
infect
sarscov
merscov
use
acut
phase
infect
crossreact
antibodi
sarscov
common
cov
observ
whole
genom
sequenc
allow
rapid
develop
molecular
diagnost
test
rtpcr
gene
encod
intern
rnadepend
rna
polymeras
surfac
spike
glycoprotein
commonli
use
support
treatment
includ
suffici
fluid
calori
intak
addit
oxygen
supplement
use
treatment
children
infect
hcov
aim
prevent
ard
organ
failur
secondari
nosocomi
infect
bacteri
infect
suspect
broadspectrum
antibiot
second
third
gener
cephalosporin
may
use
absenc
specif
antivir
drug
cov
broadspectrum
antivir
drug
interferon
alpha
beta
ribavirin
use
treatment
sarscov
includ
children
ribavirin
subsequ
shown
ineffect
even
harm
caus
hemolyt
anemia
liver
dysfunct
adult
interferonalpha
alon
togeth
ribavirin
also
consist
improv
outcom
evid
intraven
corticosteroid
led
clinic
radiolog
improv
sarscovinfect
individu
howev
systemat
review
show
evid
inconclus
corticosteroid
might
also
harm
delay
viral
clearanc
avascular
necrosi
osteoporosi
new
onset
diabet
evid
adult
studi
lopinavirritonavir
kaletra
start
earli
infect
associ
improv
clinic
outcom
decreas
intub
ard
death
rate
howev
systemat
review
found
inconclus
result
use
lopinavirritonavir
possibl
select
bia
mani
studi
inconclus
result
also
found
intraven
immunoglobulin
studi
account
comorbid
stage
ill
effect
treatment
evid
use
monoclon
antibodi
tumor
necrosi
factor
alpha
studi
treatment
outcom
merscov
children
adult
sarscov
interferon
ribavirin
alon
combin
shown
clear
benefit
mycophenol
mofetil
inhibit
guanin
therefor
rna
synthesi
identifi
potenti
antimerscov
drug
vitro
howev
anim
studi
show
drug
lead
wors
outcom
higher
viral
load
lung
extrapulmonari
tissu
consist
renal
transplant
patient
mycophenol
mofetil
report
develop
sever
sometim
fatal
merscov
infect
result
ongo
clinic
trial
becom
avail
definit
evid
base
treatment
patient
infect
treatment
recommend
children
publish
zhejiang
univers
school
medicin
suggest
use
nebul
interferon
oral
lopinavirritonavir
togeth
corticosteroid
complic
ard
enceph
hemophagocyt
syndrom
septic
shock
intraven
immunoglobulin
sever
case
howev
none
therapi
shown
clear
benefit
treatment
novel
cov
question
whether
benefici
treatment
neither
world
health
organ
us
center
diseas
control
prevent
recommend
specif
treatment
children
adult
despit
previous
mention
case
seri
children
infect
treat
lopinavirritonavir
none
children
receiv
glucocorticoid
immunoglobulin
despit
divers
cov
share
mani
protein
among
differ
speci
help
design
new
drug
one
surfac
structur
spike
glycoprotein
respons
viruscel
interact
monoclon
antibodi
convalesc
human
plasma
anim
plasma
manufactur
spike
glycoprotein
shown
inhibit
fusion
cov
human
cell
decreas
mortal
rate
sarscovinfect
patient
protein
also
inhibit
spike
glycoprotein
although
monoclon
antibodi
isol
red
alga
call
griffithsia
howev
date
test
anim
studi
angiotensinconvert
enzym
dipeptidyl
peptidas
aminopeptidas
n
oacetyl
sialic
acid
host
receptor
hcov
monoclon
antibodi
protein
might
use
treatment
infect
howev
rapid
mutat
cov
pose
potenti
problem
might
diminish
use
sever
monoclon
antibodi
target
differ
epitop
endosom
nonendosom
viru
entri
cell
reduc
inhibit
respons
proteas
papainlik
proteas
plpro
involv
viral
replic
cov
potenti
target
treatment
numer
plpro
inhibitor
identifi
howev
none
valid
vivo
studi
moreov
plpro
enzym
differ
cov
speci
make
plpro
inhibitor
narrowspectrum
antivir
drug
cov
protein
involv
viral
replic
cov
main
proteinas
inhibit
lopinavir
howev
previous
mention
lopinavir
plu
ritonavir
shown
effect
cov
anim
nonrandom
studi
sarscovinfect
human
howev
previous
mention
result
consid
inconclus
potenti
select
bia
chloroquin
commonli
use
malaria
autoimmun
diseas
increas
endosom
ph
therebi
inhibit
viruscel
fusion
therefor
potenti
broadspectrum
antivir
drug
also
interfer
glycosyl
cellular
receptor
sarscov
addit
vitro
studi
show
chloroquin
inhibit
entri
postentri
stage
cell
moreov
chloroquin
possess
immunemodul
activ
might
enhanc
antivir
effect
vivo
previous
mention
ribavirin
guanosin
analog
shown
ineffect
even
harm
sarscov
merscov
immucillina
new
adenosin
analog
recent
develop
inhibit
viral
rna
polymeras
wide
rang
rna
virus
includ
sarscov
merscov
might
use
treatment
hcov
furthermor
inhibitor
helicas
protein
unwind
doublestrand
rna
singl
strand
replic
might
use
treatment
cov
rna
synthesi
inhibitor
reduc
format
doublemembran
vesicl
hallmark
replic
identifi
potenti
antivir
drug
doublestrand
rna
activ
caspas
oligomer
draco
target
long
viral
doublestrand
rna
induc
apoptosi
infect
cell
spare
healthi
cell
might
also
use
treatment
cov
sever
vaccin
hcov
develop
aim
prevent
infect
reduc
diseas
sever
viral
shed
main
antigen
vaccin
develop
structur
spike
glycoprotein
receptorbind
domain
rbd
howev
propens
cov
rapidli
mutat
recombin
pose
potenti
problem
vaccin
develop
furthermor
enhanc
diseas
viral
challeng
postvaccin
observ
anim
model
sever
differ
vaccin
advantag
liveattenu
vaccin
usual
induc
robust
longlast
immun
respons
includ
cellular
humor
immun
mani
differ
antigen
sarscov
anim
studi
attenu
mutant
delet
structur
e
gene
shown
induc
neutral
antibodi
reduc
viral
load
protect
clinic
symptom
sarscov
infect
contrast
delet
open
read
frame
littl
effect
viral
load
vitro
vivo
strategi
develop
liveattenu
vaccin
cov
genom
rearrang
gene
knockout
advantag
vaccin
viru
recombin
wild
virus
mous
model
inactiv
vaccin
success
induc
cellular
humor
immun
mani
differ
neutral
antibodi
sar
cov
humor
immun
merscov
human
phase
trial
inactiv
vaccin
sarscov
well
toler
elicit
neutral
antibodi
howev
challeng
studi
done
human
monkey
challeng
studi
clear
evid
protect
shown
despit
induct
strong
cellular
humor
respons
moreov
concern
rais
inactiv
vaccin
sarscov
merscov
may
lead
harm
immun
andor
inflammatori
respons
postchalleng
subunit
vaccin
purifi
antigen
usual
combin
adjuv
popular
method
develop
vaccin
novel
cov
sarscov
merscov
mostli
develop
spike
glycoprotein
rbd
nucleocapsid
protein
studi
show
subunit
vaccin
given
intranas
might
induc
stronger
immun
respons
mucos
immun
sever
subunit
vaccin
shown
success
anim
challeng
studi
studi
monkey
recombin
rbd
protein
use
success
reduc
viral
load
lung
oropharynx
prevent
merscov
pneumonia
mice
similar
result
achiev
use
recombin
rbd
protein
vaccin
sarscov
adenovirusbas
vector
encod
sar
protein
eg
nucleocapsid
protein
spike
glycoprotein
membran
protein
shown
immunogen
mice
rhesu
macaqu
induc
humor
cellular
vaccin
respons
adenovirusbas
vaccin
carri
part
merscov
shown
reduc
morbid
mortal
undetect
reduc
pulmonari
viral
load
mous
model
initi
pulmonari
hemorrhag
observ
postvir
challeng
howev
ad
ligand
vaccin
enhanc
immunogen
efficaci
also
prevent
inadvert
pulmonari
patholog
make
vaccin
promis
strategi
nonetheless
preexist
immun
adenoviru
might
reduc
efficaci
might
address
give
viralbas
vaccin
follow
recombin
vaccin
booster
adenovirusbas
merscov
vaccin
move
phase
clinic
trial
one
studi
compar
inactiv
sarscov
vaccin
adenovirusbas
vaccin
sarscov
found
first
led
higher
humor
respons
adenovirusbas
vaccin
administ
intranas
led
immunoglobulin
antibodi
product
associ
superior
protect
viru
replic
lung
indic
measur
serum
neutral
antibodi
might
suffici
way
assess
vaccin
efficaci
hcov
mucos
immun
might
import
sarscov
poxviru
also
use
vector
intranas
intramuscularli
administ
vaccin
vaccineinduc
neutral
antibodi
reduc
viral
load
respiratori
tract
challeng
mice
howev
similar
vaccin
use
ferret
led
increas
liver
damag
sarscov
challeng
vector
vaccin
sarscov
test
anim
base
recombin
parainfluenza
viru
vaccin
contain
dna
encod
spike
glycoprotein
seem
induc
robust
respons
neutral
antibodi
merscov
vaccin
contain
rbd
protein
shown
protect
rhesu
macaqu
merscov
pneumonia
three
dna
vaccin
merscov
advanc
clinic
trial
due
aerosolgener
procedur
intub
bronchoscopi
appropri
hospit
hygien
practic
therefor
crucial
limit
nosocomi
outbreak
main
aim
effect
triag
patient
fever
respiratori
symptom
contact
histori
appli
stringent
infect
control
measur
isol
patient
quarantin
contact
earli
possibl
ideal
patient
place
singl
neg
pressur
room
possibl
patient
health
care
worker
cohort
protect
gear
includ
waterresist
gown
dispos
glove
mask
goggl
face
shield
suction
cathet
mechan
respir
closedcircuit
system
viral
filter
use
contrast
nebul
oxygen
mask
nasal
continu
posit
airway
pressur
system
use
open
ward
needless
say
strict
hand
hygien
need
appli
visitor
avoid
limit
absolut
minimum
hcov
shown
persist
dri
surfac
day
persist
depend
temperatur
shorter
durat
humid
longer
higher
humid
hcov
includ
novel
cov
inactiv
heat
minut
use
lipid
solvent
ethanol
isopropanol
formaldehyd
povidoneiodin
sodium
hypochlorit
hydrogen
peroxid
chlorhexidin
summari
sarscov
merscov
infect
seem
affect
children
less
commonli
less
sever
compar
adult
might
children
less
frequent
expos
main
sourc
transmiss
disproport
nosocomi
less
expos
anim
howev
could
also
children
less
frequent
symptomat
less
sever
symptom
therefor
less
often
test
lead
underestim
true
number
infect
relat
studi
prepublish
earli
march
suggest
children
like
adult
becom
infect
viru
less
like
symptomat
develop
sever
symptom
howev
import
children
transmit
viru
remain
uncertain
major
children
infect
novel
cov
report
thu
far
document
household
contact
often
show
symptom
suggest
possibl
children
import
reservoir
novel
cov
clinic
laboratori
radiolog
featur
children
similar
novel
cov
except
children
infect
sarscov
present
fever
compar
merscov
date
death
children
report
sarscov
except
case
former
infant
mother
infect
pregnanc
